Sfoglia per Autore ABRIGNANI, SERGIO
Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis
2004 C. de Lalla, G. Galli, L. Aldrighetti, R. Romeo, M. Mariani, A. Monno, S. Nuti, M. Colombo, F. Callea, S.A. Porcelli, P. Panina-Bordignon, S. Abrignani, G. Casorati, P. Dellabona
Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells
2006 S. Crotta, V. Ronconi, C. Ulivieri, C.T. Baldari, N.M. Valiente, S. Abrignani, A. Wack
Hepatitis C virus polyprotien vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 M. Vadly, M. Selby, A. Medina Selby, D. Coit, J. Hall, L. Tandeske, D. Chien, C. Hu, D. Rosa, M. Singh, J. Kazzaz, S. Nguyen, S. Coates, P. Ng, S. Abrignani, Y. Lin, M. Houghton, D.T. O'Hagan
Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line
2007 M. Brazzoli, S. Crotta, A. Bianchi, F. Bagnoli, P. Monaghan, T. Wileman, S. Abrignani, M. Merola
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 Z. Stamataki, S. Coates, M.J. Evans, M. Wininger, K. Crawford, C. Dong, Y. Fong, D. Chien, S. Abrignani, P. Balfe, C.M. Rice, J.A. Mckeating, M. Houghton
Invariant NKT cells sustain specific B cell responses and memory
2007 G. Galli, P. Pittoni, E. Tonti, C. Malzone, Y. Uematsu, M. Tortoli, D. Maione, G. Volpini, O. Finco, S. Nuti, S. Tavarini, P. Dellabona, R. Rappuoli, G. Casorati, S. Abrignani
Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector function
2008 A. Serra, S. Nuti, S. Tavarini, C. Sammicheli, D. Rosa, G. Saletti, E. Soldaini, S. Abrignani, A. Wack
The candidate HCV E1E2MF59 vaccine is safe in chronic hepatitis C patients and accellerates the second phase viral decline upon primary response to peg-interferon-2A/ribavirin therapy
2009 P. Colombatto, M.R. Brunetto, A.M. Maina, V. Romagnoli, A. Craxì, P. Almasio, S. Madonia, M.G. Rumi, M. Colombo, S. Fargion, A. Ascione, G. Pinzello, M. Mondelli, A. Muzzi, F. Bianchi, V. Barnaba, M. Sarracino, R. Rappuoli, D. Rosa, S. Montigiani, S. Abrignani, M. Houghton, F. Bonino
The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin
2009 P. Colombatto, M.R. Brunetto, A.M. Maina, V. Romagnoli, A. Craxì, P. Almasio, S. Madonia, M.G. Rumi, M. Colombo, S. Fargion, A. Ascione, G. Pinzello, M. Mondelli, A. Muzzi, F. Bianchi, V. Barnaba, M. Sarracino, R. Rappuoli, D. Rosa, S. Montigiani, S. Abrignani, M. Houghton, F. Bonino
PHENOTYPICAL CHARACTERIZATION OF THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH POTENTIAL FOR THERAPY IN NEURODEGENERATIVE DISORDERS
2009 D. Cigognini, E. Nicora, E. Ripamonti, R. Adami, S. Abrignani, M. Moro, P. Rebulla, A.M. Di Giulio, D. Bottai, A. Gorio
Third trimester human amniotic fluid cells isolation and phenothypical characterizzation
2009 D. Bottai, D. Cigognini, E. Nicora, E. Ripamonti, R. Adami, S. Abrignani, M. Moro, P. Rebulla, M. Menarini, A.M. Di Giulio, A. Gorio
Phenotypical characterization of third trimester human amniotic fluid cells: a new reservoir of stem cells?
2009 D. Bottai, D. Cigognini, E. Nicora, E. Ripamonti, R. Adami, S. Abrignani, M. Moro, P. Rebulla, M. Menarini, A.M. Di Giulio, A. Gorio
TNF-blockade enhances T cell responses to TCR stimulation in peripheral blood while it inhibits inflammatory gene expression in target tissues
2010 F. Bosè, L. Raeli, C. Garutti, E. Frigerio, F. Caprioli, G. Altomare, J. Geginat, S. Abrignani, E. Reali
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins
2011 R. Grifantini, M. Pagani, A. Pierleoni, A. Grandi, M. Parri, S. Campagnoli, P. Pileri, D. Cattaneo, E. Canidio, A. Pontillo, E. De Camilli, A. Bresciani, F. Marinoni, E. Pedrazzoli, R. Nogarotto, S. Abrignani, G. Viale, P. Sarmientos, G. Grandi
Decrease of IL-17 and Gm-Csf in intestinal mucosa of Ibd patients is associated with reduction of CD68+macrophages and clinical remission in response to anti-TNF Therapy
2011 F. Bose, F. Caprioli, R. Rossi, M. Palazzo, C. Viganò, L. Raeli, M. Moro, G. Basilisco, S. Ferrero, M. Pagani, G. Altomare, S. Abrignani, E. Reali
Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues
2011 F. Bosè, L. Raeli, C. Garutti, E. Frigerio, A. Cozzi, M. Crimi, F. Caprioli, R. Scavelli, G.F. Altomare, J. Geginat, S. Abrignani, E. Reali
Infliximab modulates IL23-TH17 axis in patients with inflammatory bowel diseases
2011 F. Caprioli, F. Bose, C. Vigano, M. Palazzo, S. Ferrero, G. Basilisco, D. Conte, S. Abrignani, E. Reali
Infliximab modulates Il23-TH17 axis in patients with inflammatory bowel diseases
2011 F. Caprioli, F. Bosè, C. Viganò, M. Palazzo, G. Basilisco, D. Conte, S. Abrignani, E. Reali
Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b
2011 R.L. Rossi, G. Rossetti, L. Wenandy, S. Curti, A. Ripamonti, R.J.P. Bonnal, R.S. Birolo, M. Moro, M.C. Crosti, P. Gruarin, S. Maglie, F. Marabita, D. Mascheroni, V. Parente, M. Comelli, E. Trabucchi, R. De Francesco, J. Geginat, S. Abrignani, M. Pagani
Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains
2011 Z. Stamataki, S. Coates, S. Abrignani, M. Houghton, J.A. Mckeating
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile